These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structure of a snake venom phospholipase A2 modified by p-bromo-phenacyl-bromide. Zhao H; Tang L; Wang X; Zhou Y; Lin Z Toxicon; 1998 Jun; 36(6):875-86. PubMed ID: 9663694 [TBL] [Abstract][Full Text] [Related]
3. Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. Dijkstra BW; Renetseder R; Kalk KH; Hol WG; Drenth J J Mol Biol; 1983 Jul; 168(1):163-79. PubMed ID: 6876174 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a porcine pancreatic phospholipase A2 mutant. A large conformational change caused by the F63V point mutation. Thunnissen MM; Franken PA; de Haas GH; Drenth J; Kalk KH; Verheij HM; Dijkstra BW J Mol Biol; 1993 Aug; 232(3):839-55. PubMed ID: 8355274 [TBL] [Abstract][Full Text] [Related]
5. Suppression by phospholipase A2 inhibitors of secretion of catecholamines from isolated adrenal medullary cells by suppression of cellular calcium uptake. Wada A; Sakurai S; Kobayashi H; Yanagihara N; Izumi F Biochem Pharmacol; 1983 Apr; 32(7):1175-8. PubMed ID: 6847709 [TBL] [Abstract][Full Text] [Related]
6. Observation of additional calcium ion in the crystal structure of the triple mutant K56,120,121M of bovine pancreatic phospholipase A2. Rajakannan V; Yogavel M; Poi MJ; Jeyaprakash AA; Jeyakanthan J; Velmurugan D; Tsai MD; Sekar K J Mol Biol; 2002 Dec; 324(4):755-62. PubMed ID: 12460575 [TBL] [Abstract][Full Text] [Related]
7. Fluorimetric analysis of phospholipase activity in Tetrahymena pyriformis GL. Kovács P; Csaba G Biosci Rep; 1999 Apr; 19(2):81-7. PubMed ID: 10888470 [TBL] [Abstract][Full Text] [Related]
8. 1H-NMR and protection studies of interactions between ligands and bovine pancreatic phospholipase A2. Williamson MP; Davis PD; Broadhurst MJ; Nixon JS Biochim Biophys Acta; 1989 Jul; 997(1-2):9-14. PubMed ID: 2752056 [TBL] [Abstract][Full Text] [Related]
9. X-ray structure of bovine pancreatic phospholipase A2 at atomic resolution. Steiner RA; Rozeboom HJ; de Vries A; Kalk KH; Murshudov GN; Wilson KS; Dijkstra BW Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):516-26. PubMed ID: 11264580 [TBL] [Abstract][Full Text] [Related]
11. First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution. Chandra V; Jasti J; Kaur P; Betzel Ch; Srinivasan A; Singh TP J Mol Biol; 2002 Jul; 320(2):215-22. PubMed ID: 12079380 [TBL] [Abstract][Full Text] [Related]
12. Role of the N-terminus in the interaction of pancreatic phospholipase A2 with aggregated substrates. Properties and crystal structure of transaminated phospholipase A2. Dijkstra BW; Kalk KH; Drenth J; de Haas GH; Egmond MR; Slotboom AJ Biochemistry; 1984 Jun; 23(12):2759-66. PubMed ID: 6466614 [TBL] [Abstract][Full Text] [Related]
13. Atomic resolution (0.97 A) structure of the triple mutant (K53,56,121M) of bovine pancreatic phospholipase A2. Sekar K; Rajakannan V; Gayathri D; Velmurugan D; Poi MJ; Dauter M; Dauter Z; Tsai MD Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Jan; 61(Pt 1):3-7. PubMed ID: 16508077 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the complex of bovine pancreatic phospholipase A2 with the inhibitor 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol, Sekar K; Eswaramoorthy S; Jain MK; Sundaralingam M Biochemistry; 1997 Nov; 36(46):14186-91. PubMed ID: 9369492 [TBL] [Abstract][Full Text] [Related]
15. Molecular modeling in the design of phospholipase A2 inhibitors. Ripka WC; Sipio WJ; Galbraith WG J Cell Biochem; 1989 Jul; 40(3):279-86. PubMed ID: 2777907 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion by nordihydroguaiaretic acid, a lipoxygenase inhibitor, and p-bromophenacyl bromide, a phospholipase A2 inhibitor. Nakadate T; Yamamoto S; Iseki H; Sonoda S; Takemura S; Ura A; Hosoda Y; Kato R Gan; 1982 Dec; 73(6):841-3. PubMed ID: 6819174 [No Abstract] [Full Text] [Related]
17. Crystallization and preliminary X-ray diffraction studies of Streptomyces phospholipase A2 in a calcium-binding form. Matoba Y; Kumagai T; Sugiyama M J Inorg Biochem; 2000 Nov; 82(1-4):221-3. PubMed ID: 11132631 [TBL] [Abstract][Full Text] [Related]
18. Crystal structures of the free and anisic acid bound triple mutant of phospholipase A2. Sekar K; Vaijayanthi Mala S; Yogavel M; Velmurugan D; Poi MJ; Vishwanath BS; Gowda TV; Jeyaprakash AA; Tsai MD J Mol Biol; 2003 Oct; 333(2):367-76. PubMed ID: 14529623 [TBL] [Abstract][Full Text] [Related]
19. Two-dimensional 1H-NMR studies of phospholipase-A2-inhibitor complexes bound to a micellar lipid-water interface. Dekker N; Peters AR; Slotboom AJ; Boelens R; Kaptein R; Dijkman R; de Haas G Eur J Biochem; 1991 Aug; 199(3):601-7. PubMed ID: 1868846 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of phospholipase A2 by protein I. Khanna NC; Hee-Chong M; Severson DL; Tokuda M; Chong SM; Waisman DM Biochem Biophys Res Commun; 1986 Sep; 139(2):455-60. PubMed ID: 2945554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]